Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group - PubMed (original) (raw)
Multicenter Study
. 1998 Oct;21(10):1670-3.
doi: 10.2337/diacare.21.10.1670.
Affiliations
- PMID: 9773728
- DOI: 10.2337/diacare.21.10.1670
Multicenter Study
Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group
M Knip et al. Diabetes Care. 1998 Oct.
Abstract
Objective: To examine the controversial issue of whether islet cell antibodies (ICAs) have a higher predictive value for progression to clinical IDDM in first-degree relatives of patients with diabetes than in the general population.
Research design and methods: ICAs were analyzed with standard immunofluorescence in two population-based groups: 765 sibs of children with recent-onset diabetes and 1,212 unaffected Finnish children <20 years of age at initial screening. Those positive for ICAs were additionally tested for antibodies to GAD (GADAs) and the protein tyrosine phosphatase-related IA-2 antigen (IA-2As). Subsequently, these subjects were observed for the manifestation of clinical IDDM over the next 7 years.
Results: The frequency of both detectable ICAs and ICA levels > or =20 Juvenile Diabetes Foundation units (JDF U) was significantly higher among the sibs than in the general population (7.8 vs. 4.1% and 4.8 vs. 2.0%, respectively; P < 0.001). The prevalence of GADAs (37/60 vs. 3/48; P < 0.001) and IA-2As (31/60 vs. 0/48; P < 0.001) was increased among ICA-positive sibs compared with ICA-positive individuals from the background population. Over the next 7 years, 24 sibs (3.1%) and 3 unrelated children positive for ICAs (0.3%) progressed to clinical diabetes. The positive predictive value of ICAs was thus 6% in the general population and 40% among the sibs (P < 0.001), or 13 and 59%, respectively (P < 0.001), with an antibody cutoff level of 20 JDF U. The positive predictive value was related to the number of positive autoantibodies in sibs, which was 57% in those with three antibodies, 50% in those with two antibodies, and only 6% in those with ICAs alone.
Conclusions: These data show that the frequency of multiple autoantibodies is substantially lower in ICA-positive children representing the general population than in ICA-positive sibs of children with IDDM. As a consequence, the predictive value of ICAs for IDDM is higher in sibs of affected children than in the general population. This finding must be taken into account when planning intervention trials aimed at preventing or delaying the manifestation of clinical diabetes in individuals from the general population who test positive for ICAs.
Similar articles
- Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA. Seissler J, et al. Diabetologia. 1996 Nov;39(11):1351-6. doi: 10.1007/s001250050582. Diabetologia. 1996. PMID: 8933004 - Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
Feeney SJ, Myers MA, Mackay IR, Zimmet PZ, Howard N, Verge CF, Rowley MJ. Feeney SJ, et al. Diabetes Care. 1997 Sep;20(9):1403-7. doi: 10.2337/diacare.20.9.1403. Diabetes Care. 1997. PMID: 9283787 - Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG. Christie MR, et al. Diabetes Care. 1997 Jun;20(6):965-70. doi: 10.2337/diacare.20.6.965. Diabetes Care. 1997. PMID: 9167107 - Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Leslie RD, Atkinson MA, Notkins AL. Leslie RD, et al. Diabetologia. 1999 Jan;42(1):3-14. doi: 10.1007/s001250051105. Diabetologia. 1999. PMID: 10027571 Review. No abstract available. - IA-2 and IA-2beta: the immune response in IDDM.
Notkins AL, Lan MS, Leslie RD. Notkins AL, et al. Diabetes Metab Rev. 1998 Mar;14(1):85-93. doi: 10.1002/(sici)1099-0895(199803)14:1<85::aid-dmr205>3.0.co;2-i. Diabetes Metab Rev. 1998. PMID: 9605631 Review.
Cited by
- Cellular requirements for diabetes induction in DO11.10xRIPmOVA mice.
Wesley JD, Sather BD, Perdue NR, Ziegler SF, Campbell DJ. Wesley JD, et al. J Immunol. 2010 Oct 15;185(8):4760-8. doi: 10.4049/jimmunol.1000820. Epub 2010 Sep 20. J Immunol. 2010. PMID: 20855871 Free PMC article. - Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.
Pipi E, Marketou M, Tsirogianni A. Pipi E, et al. World J Diabetes. 2014 Aug 15;5(4):505-10. doi: 10.4239/wjd.v5.i4.505. World J Diabetes. 2014. PMID: 25126396 Free PMC article. Review. - Retrospective assessment of islet cell autoantibodies in pancreas organ donors.
Diamantopoulos S, Allende G, Ferreira JM, Ciancio G, Burke GW, Pugliese A. Diamantopoulos S, et al. Diabetes Care. 2008 Sep;31(9):1741-2. doi: 10.2337/dc08-0652. Epub 2008 Jun 12. Diabetes Care. 2008. PMID: 18556338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous